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Background/aim: Microcystic, elongated, and fragmented (MELF) pattern is one of the myometrial invasion patterns in endometrioid
endometrial carcinoma (EEC), and it has been associated with poor prognostic parameters, especially lymphovascular space invasion
(LVSI) and lymph node metastasis (LNM). This study aims to represent the frequency of MELF pattern in EEC and the relationship
between MELF pattern with clinicopathological parameters, overall survival (OS), and disease-free survival (DFS).
Materials and methods: In this retrospective cohort study, we examined 233 patients with EEC diagnoses with the result of a total
hysterectomy and bilateral salpingo-oophorectomy between 2009 and 2014. The association of MELF pattern with risk factors such as
stage, recurrence, and survival was analysed statistically with the comparison of MELF positive and negative cases.
Results: MELF pattern was seen in 21.8% of all cases (51/233) and 23% of grade 1-2 cases (50/217). The MELF pattern showed a
significant difference among patients when they were compared according to advanced age (≥60) (p = 0.022), LVSI (p = 0.021), deep
myometrial invasion (p < 0.01), LNM (p = 0.027), and advanced FIGO stage (p = 0.043). MELF pattern was a predictive factor of LNM
in univariate logistic regression analysis but did not show significance in multivariate analysis. The Kaplan–Meier survival analysis
showed that MELF positive cases had reduced OS (66.7% vs 79.7% p = 0.003) and DFS (66.7% vs 77.5% p = 0.017) rates. In the univariate
analyses, MELF pattern was an independent prognostic factor on OS and DFS along with other parameters, while it was not observed
to maintain this effect in the multivariate analyses.
Conclusion: This study is one of the largest series examining the relationship between MELF pattern of myometrial invasion and
survival, and our results represented that the MELF pattern is associated with the worse clinical outcome since it is associated with
lymphovascular space invasion, deep myometrial invasion, lymph node metastasis, and reduced overall survival and disease-free
survival rates. Although the presence of MELF pattern is not reported in routine practice, it may be used as an indicator that will help
predict a worse outcome.
Key words: Endometrioid endometrial carcinoma, lymph node metastasis, lymphovascular space invasion, MELF pattern, myometrial
invasion, survival

1. Introduction
Endometrial cancers are the second most common cancer
of gynaecological malignancies after cervical cancer
and there are more than 380,000 new cases in 2018
[1]”abstract”:”This article provides a status report on the
global burden of cancer worldwide using the GLOBOCAN
2018 estimates of cancer incidence and mortality produced
by the International Agency for Research on Cancer, with
a focus on geographic variability across 20 world regions.
There will be an estimated 18.1 million new cancer cases

(17.0 million excluding nonmelanoma skin cancer.
Endometrioid endometrial carcinoma (EEC) is the most
common subtype and generally has a favourable prognosis
[2]. Although most cases are low-grade low-stage, variances
in clinical and histopathological features affect both patient
prognosis and treatment algorithm [2]. These prognostic
features include tumour type and grade, tumour stage,
myometrial invasion, cervical involvement, lymph node
metastasis (LNM), uterine serosal involvement, adnexal
involvement, parametrial invasion, vaginal involvement
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and lymphovascular space invasion (LVSI) [3]. Recent
literature focuses on the patterns of myometrial invasion
in EEC as a potential prognostic predictor [4–6]variable
five-year survival rates (92%-42%. Microcystic, elongated,
and fragmented (MELF) pattern, firstly described by
Murray et al., is one of the myometrial invasion patterns
in EEC [6,7]they sometimes undergo distinctive changes.
These are characterized by outpouchings from typical
neoplastic glands that become detached and often lined by
flattened epithelium, sometimes appearing as microcysts.
The glands may less often become elongated or undergo
fragmentation into small solid clusters or single cells.
For this constellation of changes, which in aggregate are
distinctive, the authors have coined the acronym MELF
(microcystic, elongated, fragmented. It is characterized
by microcysts lined by cells that often have conspicuous
eosinophilic cytoplasm and appeared squamoid, elongated
structures, sometimes slit-like lumen, and oedematous or
myxoid tissue with retraction artefact and inflammatory
cells [7]they sometimes undergo distinctive changes.
These are characterized by outpouchings from typical
neoplastic glands that become detached and often lined by
flattened epithelium, sometimes appearing as microcysts.
The glands may less often become elongated or undergo
fragmentation into small solid clusters or single cells.
For this constellation of changes, which in aggregate are
distinctive, the authors have coined the acronym MELF
(microcystic, elongated, fragmented. Fragmentation
may result in small clusters of cells or single cells, and
when only single cells are present, MELF pattern can be
easily overlooked. Its recognition is important for the
accuracy of measurement of myometrial invasion; if the
deep situated MELF pattern is not recognized, it may
lead to understaging and thus inadequate treatment [6].
Moreover, the characteristic flattened epithelium of MELF
can look like vascular endothelia and can mimic LVSI.
MELF pattern has been observed to vary from 9% to 48%
in different studies [8,9]. It is reported to be associated
with deep myometrial invasion, cervical stromal invasion,
LVSI, and LNM [10–18]elongated, and fragmented
(MELF. Nevertheless, it remains uncertain whether the
presence of the MELF pattern has a clinical significance,
because of the limited number of studies. The purpose of
this study is to examine the frequency of MELF pattern
in EEC and the relationship between MELF pattern with
clinicopathological parameters and its effect on survival.
2. Materials and methods
Ethics committee approval was obtained from the
noninvasive clinical research ethics committee of the
hospital for the study (Approval number: 1013, date:
22/10/2020). In this retrospective cohort study, we
examined 285 patients with EEC diagnoses with the

1570

result of a total hysterectomy and bilateral salpingooophorectomy between January, 2009, and December,
2014. Pelvic or pelvic and paraaortic lymphadenectomy
was performed in 212 patients. Fifty-two cases confined
to the endometrium were excluded from the study. A total
of 233 cases with myometrial invasion were reviewed
by two pathologists (SDA and SY) on hematoxylin
and eosin-stained slides. For each case, 2 to 15 slides of
tumour sections were examined. The presence or absence
of MELF pattern and histopathological features including
tumour grade, depth of myometrial invasion, presence
of LVSI, and cervical stromal invasion were evaluated.
Patient age, tumour size, presence of LNM, operation
date, presence of recurrence and its date, and date of
death were obtained from the hospital database. Tumour
size data were evaluated in a total of 153 patients since 13
patients had the macroscopically irregular appearance of
tumours and 67 patients did not have tumour size data in
the archive. Recurrence was confirmed by imaging and/
or biopsy. The tumour stage was determined according
to the 2009 International Federation of Gynaecology
and Obstetrics (FIGO) staging system. Overall survival
(OS) was calculated according to the time from the date
of operation to the date of last control or death. Diseasefree survival (DFS) was defined as the duration between
the date of operation and the date of recurrence or last
control.
MELF pattern was determined according to
the description by Murray et al. [7]they sometimes
undergo distinctive changes. These are characterized
by outpouchings from typical neoplastic glands that
become detached and often lined by flattened epithelium,
sometimes appearing as microcysts. The glands may less
often become elongated or undergo fragmentation into
small solid clusters or single cells. For this constellation
of changes, which in aggregate are distinctive, the
authors have coined the acronym MELF (microcystic,
elongated, fragmented. MELF pattern was characterized
by microcysts lined by eosinophilic cells or elongated
structures with a squamoid appearance or sometimes
slit-like glands, and oedematous or myxoid stroma with
retraction artefact and inflammatory cells. On occasion,
the fragmentation of glandular structures may result in
clusters of cells or individual cells, lying in an oedematous
or myxoid stroma. An invasive focus that fulfilled these
criteria was considered sufficient to be the identification of
the presence of the MELF pattern. MELF pattern was best
observed as a myxoid appearance within the myometrium
at the low-power examination. When the myxoid stroma
is observed at the edge of the tumour, eosinophilic tumour
cells and microcystic or fragmented glands intermingled
with inflammation approve the presence of the MELF
pattern at the high-power examination.

ALTINDAĞ et al. / Turk J Med Sci
2.1. Statistical analysis
The association of MELF pattern with age, tumour size,
tumour grade, depth of myometrial invasion, presence
of LVSI, cervical stromal invasion, LNM, recurrence, and
FIGO stage was analysed statistically to compare MELF
positive and negative cases in both all cases and grade
1-2 cases. For statistical analysis, IBM SPSS for Windows
v. 24.0 (IBM Corp., Armonk, NY) was used. The normal
distribution of the data was evaluated by analytical methods
(The Kolmogorov–Smirnov and Shapiro–Wilk tests). To
compare qualitative and quantitative parameters, t-test,
the Mann–Whitney U test, and Pearson’s chi-squared test
were used. Univariate and multivariate logistic regression
models were performed to see the predictive factors of
LNM. OS and DFS were calculated with the Kaplan–Meier
method and the effects of various variables on survival
were evaluated by using the log-rank test. Multivariate
analysis based on the results of univariate analysis of
factors affecting survival was performed by Cox regression
analysis and the proportional hazard assumption (hazard
ratio, HR) was calculated. The study was conducted at a
95% confidence interval (CI). For statistical significance, p
was determined <0.05.
3. Results
3.1. MELF pattern in endometrioid endometrial
carcinoma
There were 233 EEC cases included. MELF pattern
was detected in 51 cases (21.8%) (Figure 1). The
clinicopathological comparison of MELF positive and
negative cases in all cases is presented in Table 1. MELF
pattern was frequently observed in the deepest extent of
invasion. While in 6 cases MELF pattern was considered

a pure invasion pattern, it was seen as a predominant type
in 3 cases. In the remaining 42 cases, MELF pattern was
observed as a secondary pattern (Figure 2).
MELF presence showed significantly higher frequency
in patients older than 60 years (p = 0.022), LVSI (p =
0.021), deep myometrial invasion (p < 0.01), LNM (p =
0.027), and advanced FIGO stage (p = 0.043). The results of
univariate and multivariate logistic regression models are
given in Table 2. Based on the results of univariate logistic
regression analysis, age and grade were not included in
multivariate analysis.
During the follow-up, 3 MELF-positive patients (5.9%)
and 18 MELF-negative patients (9.9%) had a recurrence.
The recurrence site of MELF-positive cases was vaginal
in 2 patients and vaginal and distant in 1 patient. The
recurrence site of MELF-negative cases was vaginal in
1 patient, pelvic in 2 patients, abdominal in 2 patients,
distant in 9 patients, vaginal and distant in 2 patients,
vaginal and pelvic in 1 patient, and vaginal, pelvic, and
distant in 1 patient.
3.2. MELF pattern in grade 1 and 2 endometrioid
endometrial carcinoma
Clinicopathologic characteristics of all grade 1 and 2 EEC
cases (n = 217) with the comparison of MELF-positive
and -negative cases are shown in Table 3. MELF pattern
was detected in 50 cases (23%). MELF presence showed
significantly higher frequency in patients older than 60
years (p = 0.019), LVSI (p = 0.008), deep myometrial
invasion (p < 0.01), LNM (p = 0.019), and advanced FIGO
stage (p = 0.032). The results of univariate and multivariate
logistic regression models are given in Table 4. Based on
the results of univariate logistic regression analysis, age
was not included in multivariate analysis.

Figure 1. Fragmented, irregularly shaped glands located
within fibromyxoid stroma, lumen filled with histiocytic and
neutrophilic infiltration; note that individual neoplastic cells with
retraction artefact in the lower-left corner (arrows); HE x400.

Figure 2. Microcystic, elongated, and fragmented tumour gland
next to conventional tumour glands; fragmented, eosinophilic
gland lined by attenuated cells, its lumen containing infiltration,
and surrounded by fibromyxoid stroma; HE x400.
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Table 1. The clinicopathological comparison of MELF-positive and -negative cases in all cases.
MELF pattern (n (%))

Total (n (%))

p-value

Present

Absent

Total cases

51 (21.8%)

182 (78.1%)

233 (100%)

Age (years) (mean ± SD)

62.5 ± 9.1

60.3 ± 9.1

60.8 ± 9.1

0.095 a

Tumour size (cm)
(mean ± SD)

3.2 ± 1.6
(n = 33)

3.2 ± 1.9
(n = 120)

3.2 ± 1.8
(n = 153)

0.571 b

<60

16 (31.4%)

90 (49.5%)

106 (45.5%)

≥60

35 (68.6%)

92 (50.5%)

127 (54.5%)

1

28 (54.9%)

113 (62.1%)

141 (60.5%)

2

22 (43.1%)

54 (29.7%)

76 (32.6%)

3

1 (2.0%)

15 (8.2%)

16 (6.9%)

Absent

39 (76.5%)

162 (89%)

201 (86.3%)

Present

12 (23.5%)

20 (11%)

32 (13.7%)

<50%

18 (35.3%)

121 (66.5%)

139 (59.7%)

≥50%

33 (64.7%)

61 (33.5%)

94 (40.3%)

Absent

42 (82.4%)

164 (90.1%)

206 (88.4%)

Present

9 (17.6%)

18 (9.9%)

27 (11.6%)

Pelvic

17 (37.0%)

58 (34.9%)

75 (35.4%)

Pelvic and paraaortic

29 (63%)

108 (65.1%)

137 (64.6%)

Absent

36 (78.3%)

150 (90.4%)

186 (87.7%)

Present

10 (21.7%)

16 (9.6%)

26 (12.3%)

4 (40%)

10 (62.5%)

14 (53.8%)

2 (20%)

0 (0%)

2 (7.7%)

4 (40%)

6 (37.5%)

10 (38.5%)

Absent

48 (94.1%)

164 (90.1%)

212 (91%)

Present

3 (5.9%)

18 (9.9%)

21 (9%)

IA

17 (33.3%)

117 (64.3%)

134 (57.5%)

IB

18 (35.3%)

38 (20.9%)

56 (24%)

II

6 (11.8%)

10 (5.5%)

16 (6.9%)

IIIA

1 (2%)

1 (0.5%)

2 (0.9%)

IIIB

0 (0%)

1 (0.5%)

1 (0.4%)

IIIC1

3 (5.9%)

8 (4.4%)

11 (4.7%)

IIIC2

6 (11.8%)

3 (1.6%)

9 (3.9%)

IVA

0 (0%)

1 (0.5%)

1 (0.4%)

IVB

0 (0%)

3 (1.6%)

3 (1.3%)

Stages I-II

41 (80.4%)

165 (90.7%)

206 (88.4%)

Stages III-IV

10 (19.6%)

17 (9.3%)

27 (11.6%)

Age

Grade
Lymphovascular space
invasion
Myometrial invasion
Cervical stromal invasion
Lymphadenectomy
Lymph node metastasis

Isolated pelvic
Number of positive lymph
Isolated paraaortic
nodes
Pelvic and paraaortic
Recurrence

FIGO stage

FIGO stage

0.022 c

0.089 c

0.021 c
0.000 c
0.126 c
0.800 c
0.027 c

0.150 c

0.377 c

0.043 c

MELF: Microcystic, elongated, and fragmented, n: number, SD: standard deviation, FIGO: Federation of Gynaecology and Obstetrics, a
t-test, b the Mann–Whitney U test, c Pearson’s chi-squared test.
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3.3. MELF pattern and survival
Of all 233 patients, the median follow-up period was 44
months. In the Kaplan–Meier survival analysis, MELFpositive cases were found to have reduced OS and DFS
rates compared to negative cases, and it was statistically
significantly associated with OS (66.7% vs 79.7%, p =
0.003), and DFS (66.7% vs 77.5%, p = 0.017) by log-rank
test (Figure 3). Analysis of grade 1 and 2 cases showed that

MELF-positive cases with reduced OS and DFS rates when
compared to negative cases (68.0% vs 82.0%, p = 0.001;
68.0% vs 80.2%, p = 0.008) (Figure 4).
The results of univariate and multivariate analyses of
prognostic parameters affecting OS and DFS are given
in Tables 5 and 6. Based on the results of the univariate
analyses in Cox regression model with DFS, age was not
included in multivariate analyses.

Table 2. Results of univariate and multivariate analyses in the logistic regression model in all cases.
Univariate analysis

Multivariate analysis

HR

95% CI

p

HR

95% CI

p

Age (≥60)

2.064

0.855–4.983

0.107

-

-

-

Grade (G1-G2/ G3)

1.109

0.236–5.218

0.896

-

-

-

MELF pattern

2.604

1.091–6.215

0.031

1.087

0.324–3.651

0.892

Lymphovascular space invasion

35.795

12.755–100.454

0.000

24.231

7.685–76.401

0.000

Myometrial invasion

14.615

4.227–50.531

0.000

6.476

1.569–26.727

0.010

Cervical stromal invasion

7.125

2.755–18.426

0.000

4.074

1.144–14.515

0.030

HR: Hazard ratio, CI: Confidence interval

Figure 3. The Kaplan–Meier analysis showing overall survival and disease-free survival
for MELF-positive and -negative patients in all cases (p = 0.003, p = 0.017).

Figure 4. Kaplan-Meier analysis showing overall survival and disease-free survival for
MELF-positive and -negative patients in grade1 and 2 cases (p = 0.001, p = 0.008).
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Table 3. The clinicopathological comparison of MELF-positive and -negative cases in grade 1 and 2 cases.
MELF Pattern (n (%))

Present

Absent

Total (n (%))

p value

Total cases

50 (23%)

167 (77%)

217 (100%)

Age (years) (mean ± SD)

62.2 ± 8.8

60 ± 9.2

60.5 ± 9.1

0.515 a

Tumour size (cm)
(mean ± SD)

3.3 ± 1.6
(n = 32)

3.0 ± 1.7
(n = 107)

3.1 ± 1.7
(n = 139)

0.256 b

<60

16 (32%)

85 (50.9%)

101 (46.5%)

≥60

34 (68%)

82 (49.1%)

116 (53.5%)

Absent

38 (76%)

151 (90.4%)

189 (87.1%)

Present

12 (24%)

16 (9.6%)

28 (12.9%)

<50%

18 (36%)

117 (70.1%)

135 (62.2%)

≥50%

32 (64%)

50 (29.9%)

82 (37.8%)

Absent

42 (84%)

153 (91.6%)

195 (89.9%)

Present

8 (16%)

14 (8.4%)

22 (10.1%)

Pelvic

16 (35.6%)

56 (36.8%)

72 (36.5%)

Pelvic and
paraaortic

29 (64.4%)

96 (63.2%)

125 (63.5%)

Absent

3 (77.8%)

138 (90.8%)

173 (87.8%)

Present

10 (22.2%)

14 (9.2%)

24 (12.2%)

Isolated pelvic

4 (40%)

9 (64.3%)

13 (54.2%)

Isolated
paraaortic

2 (20%)

0 (0%)

2 (8.3%)

Pelvic and
paraaortic

4 (40%)

5 (35.7%)

9 (37.5%)

Absent

47 (94%)

153 (91.6%)

200 (92.2%)

Present

3 (6%)

14 (8.4%)

17 (7.8%)

IA

17 (34%)

113 (67.7%)

130 (59.9%)

IB

18 (36%)

31 (18.6%)

49 (22.6%)

II

5 (10%)

8 (4.8%)

13 (6%)

IIIA

1 (2%)

1 (0.6%)

2 (0.9%)

IIIB

0 (0%)

1 (0.6%)

1 (0.5%)

IIIC1

3 (6%)

7 (4.2%)

10 (4.6%)

IIIC2

6 (12%)

2 (1.2%)

8 (3.7%)

IVA

0 (0%)

1 (0.6%)

1 (0.5%)

IVB

0 (0%)

3 (1.8%)

3 (1.4%)

Stages I-II

40 (80%)

152 (91%)

192 (88,5%)

Stages III-IV

10 (20%)

15 (9%)

25 (11.5%)

Age
Lymphovascular space
invasion
Myometrial invasion
Cervical stromal invasion

Lymphadenectomy

Lymph node metastasis

Number of positive lymph
nodes

Recurrence

FIGO stage

FIGO stage

0.019 c
0.008 c
0.000 c
0.117 c

0.875 c

0.019 c

0.177 c

0.582 c

0.032 c

MELF: Microcystic, elongated, and fragmented, n: number, SD: standard deviation, FIGO: Federation of Gynaecology and
Obstetrics, a t-test, b the Mann–Whitney U test, c Pearson’s chi-squared test.
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Table 4. Results of univariate and multivariate analysis in the logistic regression model in all cases.
Univariate analysis

Multivariate analysis

HR

95% CI

p

HR

95% CI

p

Age (≥60)

1.888

0.768–4.641

0.166

-

-

-

MELF pattern

2.816

1.154–6.874

0.023

0.981

0.281–3.426

0.977

Lymphovascular space invasion

32.600

11.271–94.290

0.000

22.563

6.828–74.562

0.000

Myometrial invasion

15.018

4.297–52.488

0.000

7.563

1.817–31.470

0.005

Cervical stromal invasion

6.708

2.391–18.821

0.000

4.034

1.047–15.536

0.043

HR: Hazard ratio, CI: Confidence interval

Table 5. Results of univariate and multivariate analyses in Cox regression model with overall survival and disease-free survival in all
cases.
Univariate analysis

Multivariate analysis

HR

95% CI

p

HR

95% CI

p

Age (≥60)

1.982

1.131–3.472

0.017

1.480

0.804–2.725

0.208

Grade (G1-G2/ G3)

2.477

1.167–5.260

0.018

2.624

1.153–5.972

0.021

FIGO (I-II/ III-IV)

5.711

3.235–10.084

0.000

3.459

1.438–8.320

0.006

MELF pattern

2.423

1.337–4.390

0.004

1.268

0.633–2.541

0.503

Lymphovascular space invasion 3.703

2.072–6.619

0.000

0.982

0.408–2.362

0.967

Myometrial invasion

4.510

2.512–8.097

0.000

2.252

1.162–4.365

0.016

Cervical stromal invasion

5.257

2.846–9.709

0.000

2.687

1.375–5.254

0.004

Age (≥60)

1.701

0.998–2.897

0.051

-

-

-

Grade (G1-G2/ G3)

2.860

1.402–5.834

0.004

3.006

1.372–6.584

0.006

FIGO (I-II/ III-IV)

6.253

3.628–10.779

0.000

3.840

1.713–8.606

0.001

MELF pattern

2.001

1.120–3.577

0.019

1.085

0.555–2.122

0.811

Lymphovascular space invasion 3.688

2.104–6.467

0.000

1.006

0.450–2.248

0.989

Myometrial invasion

4.205

2.407–7.345

0.000

2.268

1.196–4.300

0.012

Cervical stromal invasion

5.205

2.865–49.454

0.000

2.482

1.286–4.790

0.007

Overall survival

Disease-free survival

HR: Hazard ratio, CI: Confidence interval
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Table 6. Results of univariate and multivariate analysis in Cox regression model with overall survival and disease-free survival in grade
1 and 2 cases.
Univariate analysis

Multivariate analysis

HR

95% CI

p

HR

95% CI

p

Age (≥60)

1.895

1.039–3.459

0.037

0.658

0.336–1.287

0.221

FIGO (I-II/ III-IV)

5.987

3.252–11.023

0.000

0.256

0.103–0.637

0.003

MELF pattern

2.721

1.444–5.127

0.002

0.753

0.365–1.553

0.443

Lymphovascular space invasion

3.542

1.877–6.684

0.000

0.795

0.310–2.043

0.634

Myometrial invasion

4.286

2.303–7.977

0.000

2.280

1.125–4.619

0.022

Cervical stromal invasion

4.441

2.237–8.820

0.000

0.438

0.210–0.910

0.027

Age (≥60)

1.719

0.965–3.062

0.066

-

-

-

FIGO (I-II/ III-IV)

6.767

3.768–12.151

0.000

3.937

1.711–9.060

0.001

MELF pattern

2.256

1.217–4.184

0.010

1.093

0.544–2.195

0.803

Lymphovascular space invasion

3.691

1.999–6.817

0.000

0.883

0.368–2.115

0.779

Myometrial invasion

4.266

2.339–7.780

0.000

2.570

1.297–5.091

0.007

Cervical stromal invasion

4.637

2.381–9.029

0.000

2.145

1.050–4.380

0.036

Overall survival

Disease-free survival

HR: Hazard ratio, CI: Confidence interval

3. Discussion
This large series of 233 endometrioid endometrial
carcinomas examining the relationship between MELF
pattern of myometrial invasion and clinicopathological
parameters shows that MELF pattern is associated with
LVSI, deep myometrial invasion, and LNM in both all
cases and grade 1-2 cases. Moreover, the presence of MELF
pattern is associated with reduced overall survival and
disease-free survival rates. MELF pattern was described
by Murray et al. in 2003, and since then several studies
have examined the prognostic value of MELF pattern
[10–16,18–20]. In this study, the MELF pattern was
observed in 21.8% of all cases and 23% of grade 1-2 cases.
Our prevalence is within the reported frequency of MELF
pattern in different studies which ranges from 9% to 48%
[9–18].
Although there are studies in the literature that have
not found a relationship between the presence of MELF
pattern and age [11,12,14], both Naki et al. and Eriksson
et al. reported a significant relationship between higher
mean age and MELF pattern [10,21]. In our study,
there was no significant relationship when comparing
the mean ages of MELF-positive and -negative cases.
However, a statistically significant correlation was found
when the age was divided into two groups as under and
over 60.
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Many studies in the literature have examined MELF
pattern as a predictive factor of LNM and the relation
between these two entities [9,11–19,22]. While Pelletier
et al., Joehlin-Price et al., and Han et al. reported an
association between LNM and MELF pattern in only grade
1 EEC cases, Sanci et al. and Euscher et al. reported it in
grade 1-2 EEC cases [9,13,15,17,22]. We examined both
all EEC cases and grade 1-2 cases in this study and showed
a statistically significant relationship between LNM
and MELF pattern similar to the results in the literature
[11,12,14,16,18]. When we evaluated positive lymph
nodes as isolated pelvic, isolated paraaortic, and dual
involvement, it was observed that there was no significant
difference between MELF-positive and -negative cases. In
their study where all cases harboured LVSI, that MELF
pattern is independently associated with an increased rate
of LNM [19]. Both Han et al. and Euscher et al. reported
in their studies that MELF pattern was a predictive
factor of LNM in univariate analysis, but not persisted
in multivariate analysis [9,22]. Moreover, Eriksson et al.
conducted a study to describe the sonographic features
of MELF pattern, and a significant relationship was
found between the presence of MELF pattern and LNM,
which proved significant in univariate analysis but not in
multivariate analysis [21]. While Dogan Altunpulluk et
al. found that MELF pattern was a significant predictor
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of LNM on multivariate analysis, Sanci et al. found this
result only among grade 1-2 EEC cases [14,15]. Pavlakis et
al. divided their cases into 2 groups according to whether
lymph node sampling was performed or not and stated
that MELF pattern significantly increased the possibility
of lymph node metastasis by logistic regression analysis
in the group which underwent lymphadenectomy [16].
Espinosa et al. reported that MELF pattern was not
associated with LNM by logistic regression analysis [11].
In our study, the presence of MELF pattern, LVSI, deep
myometrial invasion, and cervical stromal invasion showed
a significant correlation with LNM in univariate analyses;
only LVSI, deep myometrial invasion, and cervical stromal
invasion showed significance in multivariate analyses.
Although lymphovascular invasion is an uncommon
finding in EEC, it is the strongest independent prognostic
factor for LNM and overall survival [23,24]. Many studies
have analysed the relationship between LVSI and the
presence of MELF pattern and reported that LVSI is likely
to be associated with MELF pattern [10–12,14,18,20].
In the current study, we also reported a significant
relationship following the literature. In previous studies,
it was mentioned that LVSI and MELF pattern might be
morphologically confused and using D2-40 and cytokeratin
staining will help with this distinction [14,20]. When the
characteristic elongated, slit-like glandular epithelium of
MELF changes resembles vascular endothelium in some
cases, the presence of the fibromyxoid stromal changes
favours MELF pattern.
Myometrial invasion is an indispensable component of
FIGO staging system and an indicator of poor prognosis
[3]. Most studies noted a statistically significant result
between the depth of myometrial invasion and the
presence of the MELF pattern [10,12,14,21], whereas two
studies found no difference [11,15]. In the present study,
we revealed a significant relationship between MELF
pattern and deep myometrial invasion. MELF pattern
is frequently observed in the deepest extent of invasion
[7,20]. The inconspicuous appearance of the single cells
or small clusters of cells can lead to undetectability, and
its recognition is important for the accuracy of the depth
of myometrial invasion. Furthermore, when we examine
the relationship between FIGO staging and the presence
of the MELF pattern, a significant relationship was found
between the presence of MELF and the advanced stage in
this study similar to previous studies [12,14,21].
Zinovkin et al. reported that the observed survival
rate of patients with EEC was significantly lower in MELF
positive patients when compared with MELF negative
patients, and in multivariate analysis, MELF pattern was
an independent prognostic factor for survival [25]. Sanci
et al., in their study of grade 1-2 EEC cases, revealed that
the effect of the MELF pattern on OS was significant

whereas there were no significant differences in DFS; also,
MELF pattern has not associated with OS in multivariate
analysis [15]. In the systematic review of Prodromidou et
al., no difference was reported in DFS and disease-specific
survival in the studies observing the relationship between
MELF pattern and survival; and as a conclusion, they
had commented that the implication of MELF pattern
in survival was ill-determined [8]. In the present study,
according to the Kaplan–Meier analysis, MELF-positive
cases were significantly associated with reduced OS and
DFS in both all EEC cases and grade 1-2 cases. In the
univariate analyses, the presence of MELF pattern was
observed to be an independent prognostic factor on OS
and DFS along with other parameters (age, grade, LVSI,
myometrial invasion, cervical stromal invasion, stage),
while it was not observed to maintain this effect on the
multivariate analyses.
There are studies in the literature that conclude the
relationship between the presence of MELF and grade
differently. While 2 studies reported that MELF was
associated with high-grade tumours [10,26], the more
common observation in the previous studies was that
MELF pattern was associated with low-grade tumours
[12,14,16,20]. In this study, most of the cases were lowgrade (50/51) and grade 3 was only seen in 1 case, and no
significant relationship was found between the presence of
MELF and grade.
Multicentre studies which examined the relationship
between the presence of MELF pattern and recurrence
have reported an association between them [27,28]. Our
results indicated that only 3 MELF-positive cases had
recurrence, which was vaginal in 2 patients and vaginal
and distant in 1 patient. No significant relation was found
between MELF pattern and recurrence in our study, but in
this cohort, very few MELF-positive cases had recurrence.
In conclusion, we analysed the association between MELF
pattern and clinicopathological parameters and its effect
on survival in 233 EEC cases with myometrial invasion in
all EEC cases and grade 1-2 cases. Our results represent
that MELF pattern was associated with advanced age
(≥60), lymphovascular space invasion, deep myometrial
invasion, lymph node metastasis, and advanced FIGO
stage. In the survival analysis, MELF-positive cases were
found to have reduced overall and disease-free survival
rates compared to negative cases, yet it has no effect on
OS and DFS in the multivariate analyses. Our study has
limitations due to its retrospective nature and limitation
to a single tertiary care centre. The small number of
recurrences in this cohort decreases the strength of the
analysis. Albeit its limitations, we believe that this study
is remarkable as it is one of the largest series examining
the relationship between MELF pattern of myometrial
invasion and survival in both all EEC cases and grade
1-2 cases. Although the prognostic significance of MELF
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pattern has not been consistently demonstrated, it may
enter into our routine pathology practice in the near future
as a useful indicator of a worse outcome.
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